TradingView
zrrsys
Feb 15, 2022 5:53 PM

insiders 

NASDAQ:LRMR1D
Larimar Therapeutics, Inc.NASDAQ

Description

⋅
Shares of Larimar Therapeutics Inc. sank to new lows Tuesday after the U.S. Food and Drug Administration extended a clinical hold on the biotechnology company's sole pipeline candidate
Technical IndicatorsBeyond Technical Analysis
More